FDA Inspection 1021137 — American Red Cross-Myrtle Beach
The FDA completed an inspection of American Red Cross-Myrtle Beach on August 2, 2017 in Myrtle Beach, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 2, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Myrtle Beach, SC (United States)